image

SEC Filing Details

We are focused on the rapid design and development of new medicines based on breakthroughs in cancer research.
SEC Filing Details

Document Details

Form
424B5
Filing Date
March 15, 2023
Document Date
March 15, 2023
Form Description
Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3
Filing Group
Registration Statements
Company
Prelude Therapeutics
Issuer
PRELUDE THERAPEUTICS INC
Print Page
RSS Feeds
Email Alerts
Search